We are live on ! Find out more
RS

R Squared Portfolio holdings

AUM $190M
1-Year Est. Return 25.89%
This Fund
S&P 500
This Quarter Est. Return
+15.51%
1 Year Est. Return
+25.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
+$8.35M
Cap. Flow
-$4.65M
Cap. Flow %
-2.44%
Top 10 Hldgs %
14.08%
Holding
725
New
248
Increased
120
Reduced
140
Closed
216

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.3M
2
PEN icon
Penumbra
PEN
+$2.89M
3
ISRG icon
Intuitive Surgical
ISRG
+$1.9M
4
META icon
Meta Platforms (Facebook)
META
+$1.71M
5
COST icon
Costco
COST
+$1.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$5.96M
2
AAPL icon
Apple
AAPL
+$3.04M
3
MU icon
Micron Technology
MU
+$2.56M
4
LLY icon
Eli Lilly
LLY
+$2.13M
5
V icon
Visa
V
+$1.95M

Sector Composition

Rank Sector Weight
1 Financials 19.35%
2 Technology 17.3%
3 Industrials 15.96%
4 Healthcare 11.59%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIRS icon
451
AirSculpt Technologies
AIRS
$206M
$49K 0.03%
+10,895
New +$44.2K
EMPD
452
Empery Digital
EMPD
$92.5M
$48.6K 0.03%
+13,662
New +$61.1K
NABL icon
453
N-able
NABL
$763M
$46.3K 0.02%
+12,615
New +$52.5K
GERN icon
454
Geron
GERN
$996M
$45.5K 0.02%
+35,580
New +$50.1K
SMRT icon
455
SmartRent
SMRT
$255M
$44.4K 0.02%
37,307
-41,174
-52% -$52.3K
INDO icon
456
Indonesia Energy Corp
INDO
$46.8M
$43.9K 0.02%
16,035
-1,072
-6% -$3.27K
ALLO icon
457
Allogene Therapeutics
ALLO
$677M
$42.1K 0.02%
20,249
-24,996
-55% -$54.9K
AGEN
458
Agenus
AGEN
$372M
$41.1K 0.02%
+13,421
New +$48.1K
CSAN icon
459
Cosan
CSAN
$2.86B
$40.9K 0.02%
+14,193
New +$50.3K
ALT icon
460
Altimmune
ALT
$661M
$40.3K 0.02%
+13,264
New +$39.6K
COTY icon
461
Coty
COTY
$2.57B
$39.2K 0.02%
+18,163
New +$39.2K
CERS icon
462
Cerus
CERS
$516M
$37.1K 0.02%
12,700
-5,795
-31% -$14.1K
PROK icon
463
ProKidney
PROK
$426M
$36.4K 0.02%
17,822
+4,126
+30% +$7.55K
LUNG icon
464
Pulmonx
LUNG
$95.8M
$35.7K 0.02%
27,429
+7,649
+39% +$10.5K
UWMC icon
465
UWM Holdings
UWMC
$2.33B
$35.5K 0.02%
+15,500
New +$48.2K
FATE icon
466
Fate Therapeutics
FATE
$297M
$35.4K 0.02%
13,122
-5,402
-29% -$10K
EXFY icon
467
Expensify
EXFY
$217M
$35.1K 0.02%
+19,587
New +$22K
ABAT icon
468
American Battery Technology Co
ABAT
$381M
$34.1K 0.02%
+12,061
New +$38.6K
JELD icon
469
JELD-WEN Holding
JELD
$198M
$33.6K 0.02%
22,427
+8,034
+56% +$12.4K
LUCD icon
470
Lucid Diagnostics
LUCD
$178M
$32.7K 0.02%
30,587
+9,071
+42% +$9.78K
VFF icon
471
Village Farms International
VFF
$355M
$30.5K 0.02%
+15,247
New +$38.1K
BLNK icon
472
Blink Charging
BLNK
$85.2M
$29.8K 0.02%
46,546
-12,639
-21% -$9.15K
AKBA icon
473
Akebia Therapeutics
AKBA
$269M
$28.8K 0.02%
+25,295
New +$30.1K
CRDF icon
474
Cardiff Oncology
CRDF
$84M
$28.6K 0.02%
22,018
+10,216
+87% +$16.2K
NMRA icon
475
Neumora Therapeutics
NMRA
$246M
$28.2K 0.01%
+16,596
New +$31.6K
17 18
19
20 21

Similar funds

GWM
GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return
GP
Gridiron Partners Wexford, Pennsylvania $191M AUM 4.6% 1-Year Est. Return
EL
ES4 LLC Newport Beach, California $190M AUM
KFGG
Keystone Financial Group (Georgia) Atlanta, Georgia $191M AUM 13.82% 1-Year Est. Return
BFG
Beto Financial Group Boise, Idaho $190M AUM
AFP
Alpha Financial Partners Lexington, Kentucky $190M AUM 22.28% 1-Year Est. Return
CCC
Chesapeake Capital Corp Tampa, Florida $190M AUM 86.54% 1-Year Est. Return
NI
Niatross Investments Hong Kong $190M AUM

R Squared's Q2 2026 Portfolio in Review

As of Q2 2026, R Squared held 725 positions worth $190M, up 4.6% from $182M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

R Squared's Q2 2026 filing shows 248 new, 120 increased, 140 reduced and 216 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,795 shares worth $1.57M. The largest sale was Hologic, an estimated $5.96M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • R Squared's largest Q2 2026 buy was Meta Platforms (Facebook): 2,795 shares worth $1.57M.
  • R Squared added most to NVIDIA in Q2 2026, an estimated $3.3M increase.
  • R Squared's biggest Q2 2026 reduction was Apple, cutting an estimated $3.04M.
  • R Squared fully exited Hologic in Q2 2026, selling an estimated $5.96M.
  • R Squared's ten largest holdings make up 14% of its $190M portfolio in Q2 2026.
  • R Squared opened 248 new positions and closed 216 in Q2 2026.
  • R Squared's portfolio value rose 4.6% quarter-over-quarter to $190M.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.